List of FDA approved drugs later pulled from market in the U.S. until 2014
收藏www.statista.com2019-07-23 更新2025-01-21 收录
下载链接:
https://www.statista.com/statistics/618295/fda-approved-drugs-later-pulled-off-from-us-market/
下载链接
链接失效反馈官方服务:
资源简介:
This statistic depicts a list of selected FDA-approved prescription drugs, which were later pulled from the U.S. market. The longest running FDA-approved drug which was later recalled from the market was Darvon & Darvocet, between 1955 and 2010, which stayed in the market for 55 years. The reason for the recall was serious toxicity to the heart: between 1981 and 1999 there were over 2,110 deaths reported connected to that drug. According to the Food and Drug Adminitration (FDA), a "drug is removed from the market when its risks outweigh its benefits. A drug is usually taken off the market because of safety issues with the drug that cannot be corrected, such as when it is discovered that the drug can cause serious side effects that were not known at the time of approval."
本统计数据呈现了选定的美国食品药品监督管理局(FDA)批准的处方药清单,其中部分药品随后被撤出美国市场。在此列表中,最长时间在市场销售的、最终被召回的药品为达隆(Darvon)与达洛西特(Darvocet),其销售时间为1955年至2010年,共计55年。召回的原因为该药品对心脏具有严重的毒性:在1981年至1999年间,因该药导致超过2,110人死亡。根据食品药品监督管理局(FDA)的规定,当药品的风险超过其益处时,药品将被从市场上撤除。通常,药品因存在无法纠正的安全问题而被撤市,例如,在批准时未知的严重副作用被发现时。
提供机构:
Statista



